References
- Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66:271–289.
- Mariotto AB, Yabroff KR, Shao Y, et al. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011;103(2):117–128.
- Gerteis J, Izrael D, Deitz D, et al. Multiple chronic conditions chartbook.MD: Agency for Healthcare Research and Quality, Rockville; 2014 April 30.
- Hudson SV, Miller SM, Hemler J, et al. Cancer survivors and the patient-centered medical home. Transl Behav Med. 2012;2(3):322–331.
- Ogle KS, Swanson GM, Woods N, et al. Cancer and comorbidity: redefining chronic diseases. Cancer. 2000;88(3):653–663.
- Edwards BK, Noone AM, Mariotto AB, et al. Annual report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014;120(9):1290–1314.
- Edgington A, Morgan MA. Looking beyond recurrence: comorbidities in cancer survivors. Clin J Oncol Nurs. 2011;15(1):E3–E12.
- Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. Diabetes Care. 2010;33(7):1674–1685.
- Ward BW, Schiller JS, Goodman RA. Multiple chronic conditions among US adults: a 2012 update. Prev Chronic Dis. 2014;11:E62.
- Guy GP Jr., Yabroff KR, Ekwueme DU, et al. Healthcare expenditure burden among non-elderly cancer survivors, 2008-2012. Am J Prev Med. 2015;49(6 Suppl 5):S489–S497.
- Yabroff KR, Dowling EC, Guy GP Jr., et al. Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J Clin Oncol. 2016;34(3):259–267.
- Zheng Z, Yabroff KR, Guy GP Jr., et al. Annual medical expenditure and productivity loss among colorectal, female breast, and prostate cancer survivors in the United States. J Natl Cancer Inst. 2016;108(5):djv382.
- Ekwueme DU, Yabroff KR, Guy GP Jr., et al. Medical costs and productivity losses of cancer survivors–United States, 2008-2011. MMWR Morb Mortal Wkly Rep. 2014;63(23):505–510.
- Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer. 2008;112(11 Suppl):2577–2592.
- Hoekstra RA, Heins MJ, Korevaar JC. Health care needs of cancer survivors in general practice: a systematic review. BMC Fam Pract. 2014;15(1):94.
- Yabroff KR, Guy GP Jr., Ekwueme DU, et al. Annual patient time costs associated with medical care among cancer survivors in the United States. Med Care. 2014;52(7):594–601.
- Kent EE, Arora NK, Rowland JH, et al. Health information needs and health-related quality of life in a diverse population of long-term cancer survivors. Patient Educ Couns. 2012;89(2):345–352.
- Rosenbaum S. The patient protection and affordable care act: implications for public health policy and practice. Public Health Rep. 2011;126(1):130–135.
- The Patient Protection and Affordable Care Act. Pub. L. No. 111–148. 2010 Mar 23;124.
- Soni A. Top five most costly conditions among adults age 18 and older, 2012: Estimates for the U.S. Civilian Noninstitutionalized Adult Population. In: Statistical Brief #471. Rockville (MD): Agency for Healthcare Research and Quality; 2015 Apr. Available from: http://www.meps.ahrq.gov/mepsweb/data_files/publications/st471/stat471.shtml
- Subramanian S, Tangka FK, Sabatino SA, et al. Impact of chronic conditions on the cost of cancer care for Medicaid beneficiaries. Medicare Medicaid Res Rev. 2012;2(4):E1-E21.
- Lund JL, Yabroff KR, Ibuka Y, et al. Inventory of data sources for estimating health care costs in the United States. Med Care. 2009;47(7 Suppl 1):S127–S142.
- Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ. 1994;309(6964):1286–1291.
- Bernard DS, Farr SL, Fang Z. National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J Clin Oncol. 2011;29(20):2821–2826.
- Boltz MM, Hollenbeak CS, Schaefer E, et al. Attributable costs of differentiated thyroid cancer in the elderly Medicare population. Surgery. 2013;154(6):1363–1369. discussion 1369-1370.
- Cohen JW, Krauss NA. Spending and service use among people with the fifteen most costly medical conditions, 1997. Health Aff (Millwood). 2003;22(2):129–138.
- Davidoff AJ, Erten M, Shaffer T, et al. Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer. Cancer. 2013;119(6):1257–1265.
- Forde GK, Chang J, Ziogas A, et al. Costs of treatment for elderly women with advanced ovarian cancer in a Medicare population. Gynecol Oncol. 2015;137(3):479–484.
- Han X, Lin CC, Li C, et al. Association between serious psychological distress and health care use and expenditures by cancer history. Cancer. 2015;121(4):614–622.
- Hollenbeak CS, Kulaylat AN, Mackley H, et al. Determinants of medicare costs for elderly patients with oral cavity and pharyngeal cancers. JAMA Otolaryngol Head Neck Surg. 2015;141(7):628–635.
- Hollenbeak CS, Nikkel LE, Schaefer EW, et al. Determinants of medicare all-cause costs among elderly patients with renal cell carcinoma. J Manag Care Pharm. 2011;17(8):610–620.
- Hollenbeak CS, Stack BC Jr., Daley SM, et al. Using comorbidity indexes to predict costs for head and neck cancer. Arch Otolaryngol Head Neck Surg. 2007;133(1):24–27.
- Luo Z. Colon Cancer Treatment Costs for Medicare and Dually Eligible Beneficiaries. Health Care Financ Rev. 2009;31(1):35–50.
- Pan X, Sambamoorthi U. Health care expenditures associated with depression in adults with cancer. J Community Support Oncol. 2015;13(7):240–247.
- Yabroff KR, Borowski L, Lipscomb J. Economic studies in colorectal cancer: challenges in measuring and comparing costs. J Natl Cancer Inst Monogr. 2013;46:62–78.
- Banegas MP, Guy GP Jr., De Moor JS, et al. For working-age cancer survivors, medical debt and bankruptcy create financial hardships. Health Aff (Millwood). 2016;35(1):54–61.
- Blumberg LJ, Waidmann TA, Blavin F, et al. Trends in health care financial burdens, 2001 to 2009. Milbank Q. 2014;92(1):88–113.
- Meropol NJ, Schrag D, Smith TJ, et al. American society of clinical oncology guidance statement: the cost of cancer care. J Clin Oncol. 2009;27(23):3868–3874.
- National Cancer Policy Forum; Board on Health Care Services; Institute of Medicine. Ensuring patient access to affordable cancer drugs: workshop summary. Washington (DC): National Academies Press (US); 2014 Dec 23. Workshop Summary. [cited 2016 May 2]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK268684/Accessed.
- Leroy L, Bayliss E, Domino M, et al. The agency for healthcare research and quality multiple chronic conditions research network: overview of research contributions and future priorities. Med Care. 2014;52(Suppl 3):S15–S22.
- Grembowski D, Schaefer J, Johnson KE, et al. A conceptual model of the role of complexity in the care of patients with multiple chronic conditions. Med Care. 2014;52(Suppl 3):S7–S14.
- Page RD, Newcomer LN, Sprandio JD, et al. The patient-centered medical home in oncology: from concept to reality. Am Soc Clin Oncol Educational Book /ASCO. Am Soc Clin Oncology. Meet. 2015;35:e82–e89.
- Thorpe KE, Ogden LL, Galactionova K. Chronic conditions account for rise in Medicare spending from 1987 to 2006. Health Aff (Millwood). 2010;29(4):718–724.
- U.S. Department of Health and Human Services. Multiple chronic conditions – a strategic framework: optimum health and quality of life for individuals with multiple chronic conditions. Washington (DC): U.S. Department of Health and Human Services; 2010 Dec.
- Anderson G. Chronic care: making the case for ongoing care. Princeton (NJ): Robert Wood Johnson Foundation; 2010.
- Warren JL, Klabunde CN, Schrag D, et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(8 Suppl):IV-3-18.
- Cohen JW, Cohen SB, Banthin JS. The medical expenditure panel survey: a national information resource to support healthcare cost research and inform policy and practice. Med Care. 2009;47(7 Suppl 1):S44–S50.
- Byrne J, Kessler LG, Devesa SS. The prevalence of cancer among adults in the United States: 1987. Cancer. 1992;69(8):2154–2159.
- Hewitt M, Breen N, Devesa S. Cancer prevalence and survivorship issues: analyses of the 1992 National health interview survey. J Natl Cancer Inst. 1999;91(17):1480–1486.
- Guy GP Jr., Ekwueme DU, Yabroff KR, et al. Economic burden of cancer survivorship among adults in the United States. J Clin Oncol. 2013;31(30):3749–3757.
- Dowling EC, Chawla N, Forsythe LP, et al. Lost productivity and burden of illness in cancer survivors with and without other chronic conditions. Cancer. 2013;119:3393–3401.
- Yabroff KR, Warren JL, Banthin J, et al. Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source? Med Care. 2009;47(7 Suppl 1):S64–S69.
- Howlader N, Noone AM, Krapcho M, et al. editors. SEER cancer statistics review. Bethesda (MD): National Cancer Institute; 1975–2012. Available from: http://seer.cancer.gov/csr/1975_2012/. Based on November 2014 SEER data submission, posted to the SEER web site, April 2015.
- Weir HK, Thompson TD, Soman A, et al. Meeting the healthy people 2020 objectives to reduce cancer mortality. Prev Chronic Dis. 2015;12:E104.
- Rim SH, Hall IJ, Fairweather ME, et al. Considering racial and ethnic preferences in communication and interactions among the patient, family member, and physician following diagnosis of localized prostate cancer: study of a US population. Int J Gen Med. 2011;4:481–486.